Protection of rat cardiac myocytes by fructose-1,6-bisphosphate and 2,3-butanedione
- PMID: 22558110
- PMCID: PMC3338745
- DOI: 10.1371/journal.pone.0035023
Protection of rat cardiac myocytes by fructose-1,6-bisphosphate and 2,3-butanedione
Abstract
Earlier studies by our group showed that fructose-1,6-bisphosphate (FBP) enhances the hypothermic preservation of rat cardiac myocytes and the functional recovery of animal hearts after hypothermic storage. However, the mechanisms involved were not clear. We extended the cardiomyocyte studies by testing whether the FBP effects were due to chelation of extracellular calcium, leading to lower intracellular levels. We also tested effects of 2,3-butanedione monoxime (BDM), pyruvate, and adenine nucleotide precursors. Cardiomyocytes were incubated in ischemic suspension at 3 °C, and aliquots examined over 48 to 72 hours for retention of rod-shaped morphology, a measure of viability. Cytosolic Ca(2+) levels were measured in some experiments. FBP at 5 mM reduced the death rate even when added after one or two days of incubation. It caused cytosolic calcium levels that were 33% lower than controls in freshly-isolated cells and 70% lower after one day of incubation. EGTA protected against cell death similarly to FBP. These results indicated that one of the mechanisms by which FBP exerts protective effects is through chelation of extracellular calcium. BDM was strongly protective and reduced cytosolic calcium by 30% after one day of incubation. As with FBP, BDM was effective when added after one or two days of incubation. BDM may be useful in combination with FBP in preserving heart tissue. Pyruvate, adenine, and ribose provided little or no protection during hypothermia.
Conflict of interest statement
Figures






Similar articles
-
Fructose-1,6-bisphosphate enhances hypothermic preservation of cardiac myocytes.J Heart Lung Transplant. 2005 Sep;24(9):1378-84. doi: 10.1016/j.healun.2004.08.013. J Heart Lung Transplant. 2005. PMID: 16143260
-
2,3-Butanedione monoxime does not protect cardiomyocytes under oxidative stress.Cell Biochem Funct. 2006 Sep-Oct;24(5):413-8. doi: 10.1002/cbf.1277. Cell Biochem Funct. 2006. PMID: 16142696
-
Mitochondrial respiratory inhibition by 2,3-butanedione monoxime (BDM): implications for culturing isolated mouse ventricular cardiomyocytes.Physiol Rep. 2016 Jan;4(1):e12606. doi: 10.14814/phy2.12606. Physiol Rep. 2016. PMID: 26733241 Free PMC article.
-
Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia.J Mol Cell Cardiol. 1991 Sep;23(9):1001-14. doi: 10.1016/0022-2828(91)91636-6. J Mol Cell Cardiol. 1991. PMID: 1942093
-
2,3-butanedione monoxime unmasks Ca(2+)-induced NADH formation and inhibits electron transport in rat hearts.Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1839-48. doi: 10.1152/ajpheart.2000.279.4.H1839. Am J Physiol Heart Circ Physiol. 2000. PMID: 11009471
Cited by
-
Functional evaluation of rat hearts transplanted after preservation in a high-pressure gaseous mixture of carbon monoxide and oxygen.Sci Rep. 2016 Aug 26;6:32120. doi: 10.1038/srep32120. Sci Rep. 2016. PMID: 27562456 Free PMC article.
-
Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.Stem Cells Transl Med. 2016 May;5(5):658-69. doi: 10.5966/sctm.2015-0238. Epub 2016 Mar 29. Stem Cells Transl Med. 2016. PMID: 27025693 Free PMC article.
-
A Roadmap to Cardiac Tissue-Engineered Construct Preservation: Insights from Cells, Tissues, and Organs.Adv Mater. 2021 Jul;33(27):e2008517. doi: 10.1002/adma.202008517. Epub 2021 May 28. Adv Mater. 2021. PMID: 34048090 Free PMC article. Review.
References
-
- Cobert ML, Peltz M, West LM, Merritt ME, Jessen ME. J Surg Res. In press; 2011. Glucose is an ineffective substrate for preservation of machine perfused donor hearts. - PubMed
-
- Chien S. Metabolic management. In: Toledo-Pereyra LH, editor. Organ preservation for transplantation, 3rd edition. Austin: Landes Bioscience; 2010. pp. 82–123.
-
- Niu W, Zhang F, Ehringer W, Tseng M, Gray L, et al. Enhancement of hypothermic heart preservation with fructose 1,6-diphosphate. J Surg Res. 1999;85:120–129. - PubMed
-
- Hirokawa F, Nakai T, Yamaue H. Storage solution containing fructose-1,6-bisphosphate inhibits the excess activation of Kupffer cells in cold liver preservation. Transplantation. 2002;74:779–783. - PubMed
-
- Didlake R, Kirchner KA, Lewin J, Bower JD, Markov A. Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat. Circ Shock. 1985;16:205–212. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous